Haemonetics Corporation (HAE) Stock

Haemonetics Corporation is a prominent healthcare company that specializes in providing innovative medical products and comprehensive solutions across the healthcare spectrum. Operating through three distinct segments Plasma, Blood Center, and Hospital the company offers a wide array of advanced technologies and services tailored to enhance medical processes and patient outcomes.

In its Plasma segment, Haemonetics Corporation delivers automated plasma collection devices, essential disposables, and cutting-edge software solutions like NexSys PCS and PCS2. These technologies are pivotal in plasmapheresis procedures, allowing plasma customers to efficiently manage donor operations and supply chain logistics. The company also provides the NexLynk DMS donor management system, which streamlines donor data management and enhances operational efficiency.

The Blood Center segment focuses on automated blood component and manual whole blood collection systems, including the renowned MCS brand apheresis equipment. These systems are designed to collect specific blood components vital for various medical procedures. Haemonetics' portfolio also includes disposable whole blood collection sets and storage solutions, complemented by the SafeTrace Tx blood bank information system and BloodTrack blood management software, which integrates hardware and software for comprehensive blood management in hospitals.

Furthermore, Haemonetics offers a range of hospital products under its Hospital segment, such as TEG, ClotPro, and HAS hemostasis analyzer systems. These systems provide clinicians with detailed assessments of patients' hemostasis, facilitating informed treatment decisions. The TEG Manager software enhances accessibility to test results across hospital networks, enabling remote monitoring and analysis.

Founded in 1971 and headquartered in Boston, Massachusetts, Haemonetics Corporation operates globally, utilizing a direct sales force, independent distributors, and sales representatives to market and distribute its innovative products and solutions. With a commitment to advancing healthcare through technology and service excellence, Haemonetics continues to play a crucial role in transforming medical practices and improving patient care worldwide.